Mereo Biopharma Group Plc - ADR
MREO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$45.19M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $45.19 Million |
|---|---|
| Enterprise Value | $16.10 Million |
| Earnings per Share | $-0.26 |
| Beta | 0.3 |
| Outstanding Shares | 160,712,541 |
Return
| Return on Equity | -98.03% |
|---|---|
| Return on Assets | -80.91% |
| Return on Invested Capital | -117.09% |
Valuation & Multiples
| P/E Ratio | -1.55 |
|---|---|
| PEG | 2.99 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.47 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$2.33 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$4.61 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 14.05% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 35.23% |
|---|---|
| Total Invested | $603▼ 100.00% |
| Investors Holding | 1▼ 62.00% |
About Mereo Biopharma Group Plc
2,020 employees
CEO: Denise Pollard-Knight
Mereo BioPharma is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for oncology and rare diseases. The Company has developed a portfolio of six clinical...